Literature DB >> 22140602

An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

Richard Li1, Philip Alex, Mei Ye, Ting Zhang, Ling Liu, Xuhang Li.   

Abstract

Inflammatory Bowel Disease (IBD) is a chronic and frequently disabling inflammatory disorder of the intestine. New developments in IBD therapy are primarily focused on biologic treatments; however, they are both expensive and associated with significant side effects. Here, we provide the first preclinical evidence that YunNan BaiYao (YNBY), a well-known traditional Chinese herbal remedy frequently used for treating hemorrhages and wounds, can effectively alleviate experimental colitis. Oral administration of YNBY in drinking water significantly reduced the disease activities of both DSS- and TNBS-induced experimental colitis. Mechanistic studies revealed that the effectiveness of YNBY was not due to an anti-bacterial function since YNBY had no effect on E. coli growth. Rather, it exhibited an anti-inflammatory or immunosuppressive function: In the DSS colitis model, YNBY treatment decreased the levels of several pro-inflammatory cytokines in colonic mucosa, including TNFα, IL-12p40, and IL-17. Similar cytokine changes were also observed in mouse serum, suggesting that systemic changes in general reflect the changes in the affected colon. Significant down-regulation of IL-12p40 and IL-17, in addition to IFNγ, was also seen in TNBS-colitis model. Another potential mechanism for the anti-inflammatory effects of YNBY involves the selective suppression of pro-inflammatory immune cells: YNBY effectively suppressed the growth of multiple T- and B-lymphocytes, including Molt-4, Jurkat, and EBV-transformed human B-lymphocytes, more potently than 6-mecaptopurine (6-MP) and 5-aminosalicylic acid (5-ASA), two of the most commonly used first-line drugs in IBD therapy. In sharp contrast, YNBY exhibited no cytotoxicity to colonic epithelial cells (Caco-2 cells), even at the concentration 10-fold higher than that used in the lymphocyte model; and instead promoted cell spreading and wound healing. These results strongly suggest that YNBY not only has effective anti-inflammatory properties through suppressing lymphocyte growth and pro-inflammatory cytokine expression, but also can promote intestinal epithelial wound-healing and repair. Therefore, YNBY demonstrates strong potential as an alternative herbal therapy for IBD.

Entities:  

Keywords:  Crohn's disease; DSS-colitis; IBD; TNBS-colitis; YunNan BaoYao (YNBY); complementary and alternative medicine (CAM); cytokines; herbal medicine; immunesuppression; wound healing

Year:  2011        PMID: 22140602      PMCID: PMC3228586     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  47 in total

1.  The escalating cost and prevalence of alternative medicine.

Authors:  Alastair H MacLennan; David H Wilson; Anne W Taylor
Journal:  Prev Med       Date:  2002-08       Impact factor: 4.018

Review 2.  Commensal flora: wolf in sheep's clothing.

Authors:  Ramnik Xavier; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 3.  New therapies for the treatment of inflammatory bowel disease.

Authors:  Bruce E Sands
Journal:  Surg Clin North Am       Date:  2006-08       Impact factor: 2.741

Review 4.  Traditional Chinese medicine and Kampo: a review from the distant past for the future.

Authors:  F Yu; T Takahashi; J Moriya; K Kawaura; J Yamakawa; K Kusaka; T Itoh; S Morimoto; N Yamaguchi; T Kanda
Journal:  J Int Med Res       Date:  2006 May-Jun       Impact factor: 1.671

Review 5.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

6.  Identification of nanofibers in the Chinese herbal medicine: Yunnan Baiyao.

Authors:  Scott C Lenaghan; Lijin Xia; Mingjun Zhang
Journal:  J Biomed Nanotechnol       Date:  2009-10       Impact factor: 4.099

Review 7.  Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?

Authors:  Ann Flynn; Sunanda Kane
Journal:  Curr Opin Gastroenterol       Date:  2011-07       Impact factor: 3.287

Review 8.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

Authors:  Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 9.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

10.  Effects of the preoperative administration of Yunnan Baiyao capsules on intraoperative blood loss in bimaxillary orthognathic surgery: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Z-L Tang; X Wang; B Yi; Z-L Li; C Liang; X-X Wang
Journal:  Int J Oral Maxillofac Surg       Date:  2009-01-18       Impact factor: 2.789

View more
  16 in total

1.  The effects of oral administration of Yunnan Baiyao on blood coagulation in beagle dogs as measured by kaolin-activated thromboelastography and buccal mucosal bleeding times.

Authors:  Jami Frederick; Søren Boysen; Catherine Wagg; Serge Chalhoub
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

Review 2.  The efficacy of Yunnan Baiyao on haemostasis and antiulcer: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Bo Yang; Zhe-Qi Xu; Hao Zhang; Feng-Ying Xu; Xue-Yin Shi; Zui Zou; Chang-Quan Ling; Ling Tang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  Topical Yunnan Baiyao administration as an adjunctive therapy for bleeding complications in adolescents with advanced cancer.

Authors:  E J Ladas; J B Karlik; D Rooney; K Taromina; D H Ndao; L Granowetter; K M Kelly
Journal:  Support Care Cancer       Date:  2012-10-04       Impact factor: 3.603

4.  An aqueous extract of Yunnan Baiyao inhibits the quorum-sensing-related virulence of Pseudomonas aeruginosa.

Authors:  Zu-Guo Zhao; Shuang-Shuang Yan; Yun-Mei Yu; Na Mi; La-Xi Zhang; Jun Liu; Xiao-Ling Li; Fang Liu; Jun-Fa Xu; Wei-Qing Yang; Guo-Ming Li
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

5.  Effects of Yunnan Baiyao on the Differentiation of HPDLFs on the Bio-Oss® Collagen Scaffold in vivo.

Authors:  Xiaohong Yu; Jing Wang; Qianqian Han; Wen Chu; Shaowen Lu; Yu Liu; Yi Peng; Jie Xu; Yanqing Shui
Journal:  Int J Gen Med       Date:  2022-06-03

6.  Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.

Authors:  Jingjing Zhang; Wei Dou; Eryun Zhang; Aning Sun; Lili Ding; Xiaohui Wei; Guixin Chou; Sridhar Mani; Zhengtao Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-14       Impact factor: 4.052

Review 7.  Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.

Authors:  Maciej Sałaga; Hubert Zatorski; Marta Sobczak; Chunqiu Chen; Jakub Fichna
Journal:  Curr Treat Options Oncol       Date:  2014-09

8.  Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption.

Authors:  Xuewei Wang; Fugang Fan; Qin Cao
Journal:  Mol Med Rep       Date:  2016-06-02       Impact factor: 2.952

9.  Repurposing of yunnan baiyao as an alternative therapy for minor recurrent aphthous stomatitis.

Authors:  Xiaosong Liu; Xiaobing Guan; Ruiyang Chen; Hong Hua; Yang Liu; Zhimin Yan
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-04       Impact factor: 2.629

Review 10.  Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies.

Authors:  John K Triantafillidis; Aikaterini Triantafyllidi; Constantinos Vagianos; Apostolos Papalois
Journal:  Ann Gastroenterol       Date:  2016-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.